b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29382323</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>13</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>11</Month>\n            <Day>13</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1471-2407</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>18</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>01</Month>\n                        <Day>30</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>BMC cancer</Title>\n                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>112</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4033-2</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">The new nine-valent vaccine against human papillomavirus (HPV) includes the four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV vaccine, plus five additional oncogenic types (31, 33, 45, 52, and 58) remain significantly associated with high grade lesions. We aimed to determine the prevalence of high-risk HPV genotypes in unvaccinated subjects and the association of these genotypes with the incidence of high-grade lesions. We also assessed which, if either, of these two HPV vaccines could have prevented these cases.</AbstractText>\n                <AbstractText Label="METHODS">This cross-sectional study, conducted from 4 January 2010 to 30 December 2011, was composed of 595 women attending the Hospital General Universitario de Elche (Spain) gynaecology department who were positively screened for opportunistic cervical cancer by pap smears and HPV detection during a routine gynaecological health check. The pap smear results were classified using the Bethesda system. HPV genotyping was performed with the Linear Array HPV genotyping test, and viruses were classified by the International Agency for Research on Cancer assessment of HPV carcinogenicity. Odds ratios (ORs) with their 95% confidence intervals (95% CI) were estimated by logistic regression, adjusting for age and immigrant status. The prevented fraction among those exposed (PFe-adjusted) was determined as a measure of impact.</AbstractText>\n                <AbstractText Label="RESULTS">At least one of the additional five high-risk HPV genotypes present in the nine-valent HPV vaccine was detected in 20.5% of subjects. After excluding women with genotype 16 and/or 18 co-infection, high-risk genotypes (31, 33, 45, 52, and 58) were associated with a higher risk of intraepithelial lesion or malignancy: adjusted OR\xe2\x80\x89=\xe2\x80\x893.51 (95% CI, 1.29-9.56), PFe-adjusted\xe2\x80\x89=\xe2\x80\x890.72 (95% CI, 0.22-0.90). Genotypes that are still non-vaccine-targeted were detected in 17.98% of the women, but these were not significantly associated with high-grade lesions.</AbstractText>\n                <AbstractText Label="CONCLUSION">The greater protection of the nine-valent HPV vaccine is likely to have a positive impact because, in the absence of genotype 16 or 18 infection, these five genotypes on their own remained significantly associated with high-grade lesions.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Paz-Zulueta</LastName>\n                    <ForeName>Mar\xc3\xada</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Faculty of Nursing, University of Cantabria, Avda Valdecilla s/n. C.P.: 39008, Cantabria, Spain. maria.paz@unican.es.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>\xc3\x81lvarez-Paredes</LastName>\n                    <ForeName>Ledicia</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Microbiology and Parasitology, University Hospital of Burgos, C/ Islas Baleares, 3 - C.P.: 09006, Burgos, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rodr\xc3\xadguez D\xc3\xadaz</LastName>\n                    <ForeName>Juan Carlos</ForeName>\n                    <Initials>JC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Microbiology, University General Hospital of Alicante. Pintor Baeza, 11- C.P.: 03010, Alicante, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Par\xc3\xa1s-Bravo</LastName>\n                    <ForeName>Paula</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Faculty of Nursing, University of Cantabria, Avda Valdecilla s/n. C.P.: 39008, Cantabria, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Andrada Becerra</LastName>\n                    <ForeName>Ma Encarnaci\xc3\xb3n</ForeName>\n                    <Initials>ME</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathological Anatomy, University General Hospital of Elche. Cam\xc3\xad de l\'Almazara, 11 - C.P.: 03203, Alicante, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rodr\xc3\xadguez Ingelmo</LastName>\n                    <ForeName>Jos\xc3\xa9 Mar\xc3\xada</ForeName>\n                    <Initials>JM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Gynecology, University General Hospital of Elche. Cam\xc3\xad de l\'Almazara, 11 - C.P.: 03203, Alicante, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ruiz Garc\xc3\xada</LastName>\n                    <ForeName>Mar\xc3\xada Montserrat</ForeName>\n                    <Initials>MM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Microbiology, University General Hospital of Elche. Cam\xc3\xad de l\'Almazara, 11 - C.P.: 03203, Alicante, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Portilla</LastName>\n                    <ForeName>Joaqu\xc3\xadn</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Infectious Diseases, University Hospital of Alicante. Pintor Baeza, 11- C.P.: 03010, Alicante, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Santiba\xc3\xb1ez</LastName>\n                    <ForeName>Miguel</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Faculty of Nursing, University of Cantabria, Avda Valdecilla s/n. C.P.: 39008, Cantabria, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>30</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>BMC Cancer</MedlineTA>\n            <NlmUniqueID>100967800</NlmUniqueID>\n            <ISSNLinking>1471-2407</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D053918">Papillomavirus Vaccines</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D052162" MajorTopicYN="N">Human papillomavirus 16</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D052161" MajorTopicYN="N">Human papillomavirus 18</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D030361" MajorTopicYN="N">Papillomavirus Infections</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053918" MajorTopicYN="N">Papillomavirus Vaccines</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000073887" MajorTopicYN="Y">Vaccination Coverage</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014626" MajorTopicYN="N">Vaginal Smears</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>03</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>01</Month>\n                <Day>23</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>2</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>2</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29382323</ArticleId>\n            <ArticleId IdType="doi">10.1186/s12885-018-4033-2</ArticleId>\n            <ArticleId IdType="pii">10.1186/s12885-018-4033-2</ArticleId>\n            <ArticleId IdType="pmc">PMC5791190</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Int J Cancer. 2015 Mar 1;136(5):E359-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25220842</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Feb 19;372(8):711-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25693011</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2010 Mar 3;102(5):325-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20139221</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Vaccine. 2013 Oct 25;31(45):5152-67</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24029117</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2010 Nov;11(11):1048-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20952254</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Vaccine. 2014 Sep 3;32(39):5087-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25018097</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gynecol Oncol. 2014 Sep;134(3):534-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24979052</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Open Virol J. 2009 Sep 04;3:60-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19750125</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2007 May 10;356(19):1928-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17494926</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 2010 Oct 6;102(19):1478-88</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20841605</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CA Cancer J Clin. 2012 May-Jun;62(3):147-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22422631</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Vaccin Immunother. 2017 Aug 3;13(8):1839-1843</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28594305</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Cancer. 2012 Nov 20;12:533</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23167826</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Vaccine. 2012 Jul 27;30(35):5215-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22713720</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Infect. 2013 Mar;66(3):207-17</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23103285</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>APMIS. 2011 Mar;119(3):204-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21284738</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Infect Dis. 2009 Apr 1;199(7):926-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19236279</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Infect Dis. 2017 Jan;17 (1):68-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27282422</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Med Screen. 2011;18(1):41-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21536816</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Vaccine. 2012 Nov 20;30 Suppl 5:F12-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23199955</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Cancer Prev. 2014 May;23(3):206-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24129107</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2011 Feb 15;128(4):927-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20473886</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2007 Feb 28;297(8):813-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17327523</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2003 Feb 6;348(6):518-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12571259</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Infect Agent Cancer. 2012 Dec 29;7(1):38</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23273245</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1997-2008</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25274978</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2012 Jan;13(1):89-99</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22075171</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2002 Apr 24;287(16):2114-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11966386</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2008 Nov 15;113(10 Suppl):3036-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18980286</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Enferm Infecc Microbiol Clin. 2012 May;30(5):230-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22206950</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Wkly Epidemiol Rec. 2013 Jul 19;88(29):301-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23909011</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Gynecol Cancer. 2011 Aug;21(6):1150-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21792018</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Vaccine. 2009 Jan 22;27(4):581-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19022320</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cytol. 2013 Jan;30(1):33-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23661938</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Obstet Gynecol. 2012 Jan;206(1):46.e1-46.e11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21944226</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Vaccine. 2012 Nov 20;30 Suppl 5:F123-38</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23199956</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Cancer. 2011 Jun 28;105(1):28-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21629249</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2012 Jan;13(1):100-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22075170</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Med Virol. 2012 Jun;84(6):947-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22499018</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2012 Nov 15;131(10):2349-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22323075</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Infect Dis. 2007 Jul;7(7):453-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17597569</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Infect Agent Cancer. 2009 Jun 01;4:8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19486508</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2010 Mar;21(3):448-58</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20176693</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2007 May 10;356(19):1915-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17494925</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Scand J Infect Dis. 2014 Nov;46(11):737-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25189272</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gynecol Oncol. 2014 Jun;133(3):405-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24657488</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18354839</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'